ABALLI JOHN
President and CEO
ABALLI JOHN has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.
On the most recent filing, ABALLI JOHN is listed as President and CEO at EXAGEN INC. Inside the rolling window, ABALLI JOHN reported no open-market purchases and 3 open-market sales totaling $368K in XGN. The largest disclosed transaction in the window is a sale of 34,294 XGN shares on Oct 16, 2026, worth $270K.
Companies traded
Other insiders at XGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$368K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 16, 2025 | XGN | Sale | $376K |
Frequently asked questions
How many SEC Form 4 filings has ABALLI JOHN made?
ABALLI JOHN has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does ABALLI JOHN trade?
ABALLI JOHN has filed SEC Form 4 disclosures for 1 company, including XGN.
When was ABALLI JOHN's most recent SEC Form 4 filing?
ABALLI JOHN's most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.
What is ABALLI JOHN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ABALLI JOHN is listed as President and CEO.
What is ABALLI JOHN's total buy and sell value in the current window?
Inside the rolling retention window, ABALLI JOHN bought $0 and sold $368K based on SEC Form 4 filings.
What was ABALLI JOHN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,294 XGN shares on 2026-10-16, worth $270K, per SEC Form 4 filings.